Concurrent methylation of promoters from tumor associated genes predicts outcome in acute myeloid leukemia

References

• Gilliland D G, Jordan C T, Felix C A. The molecular basis of leukemia. Hematology (Am Soc Hematol Educ Program) 2004; 80–97
   PubMedGoogle Scholar
• Marcucci G, Mrozek K, Bloomfield C D. Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics. Curr Opin Hematol 2005; 12: 68–75
   PubMed Web of Science ®Google Scholar
• Alvarez S, Cigudosa J C. Gains, losses and complex karyotypes in myeloid disorders: a light at the end of the tunnel. Hematol Oncol 2005; 23: 18–25
   PubMed Web of Science ®Google Scholar
• Jabbour E J, Estey E, Kantarjian H M. Adult acute myeloid leukemia. Mayo Clin Proc 2006; 81: 247–260
   PubMed Web of Science ®Google Scholar
• Higuchi M, O'Brien D, Kumaravelu P, Lenny N, Yeoh E J, Downing J R. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 2002; 1: 63–74
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhou L, Miyamoto T, Iwasaki H, Harakawa N, Hetherington C J, et al. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci USA 2001; 98: 10398–10403
   PubMed Web of Science ®Google Scholar
• de Guzman C G, Warren A J, Zhang Z, Gartland L, Erickson P, Drabkin H, et al. Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation. Mol Cell Biol 2002; 22: 5506–5517
   PubMed Web of Science ®Google Scholar
• Fenske T S, Pengue G, Mathews V, Hanson P T, Hamm S E, Riaz N, et al. Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice. Proc Natl Acad Sci USA 2004; 101: 15184–15189
   PubMed Web of Science ®Google Scholar
• Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16: 6–21
   PubMed Web of Science ®Google Scholar
• Jones P A, Laird P W. Cancer epigenetics comes of age. Nat Genet 1999; 21: 163–167
   PubMed Web of Science ®Google Scholar
• Ekmekci C G, Gutierrez M I, Siraj A K, Ozbek U, Bhatia K. Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia. Am J Hematol 2004; 77: 233–240
   PubMed Web of Science ®Google Scholar
• Melki J R, Vincent P C, Clark S J. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 1999; 59: 3730–3740
   PubMed Web of Science ®Google Scholar
• Li Q, Kopecky K J, Mohan A, Willman C L, Appelbaum F R, Weick J K, et al. Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia. Clin Cancer Res 1999; 5: 1077–1084
   PubMed Web of Science ®Google Scholar
• Li M, Lou F D, Lu X C, Jin H J, Yu L. [The study on methylation of gene IGSF4 promoter in acute leukemia cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2004; 12: 125–127
   PubMedGoogle Scholar
• Shimamoto T, Ohyashiki J H, Ohyashiki K. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia. Leuk Res 2005; 29: 653–659
   PubMed Web of Science ®Google Scholar
• Aggerholm A, Holm M S, Guldberg P, Olesen L H, Hokland P. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients. Eur J Haematol 2006; 76: 23–32
   PubMed Web of Science ®Google Scholar
• Issa J P, Zehnbauer B A, Civin C I, Collector M I, Sharkis S J, Davidson N E, et al. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 1996; 56: 973–977
   PubMed Web of Science ®Google Scholar
• Issa J P, Baylin S B, Belinsky S A. Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res 1996; 56: 3655–3658
   PubMed Web of Science ®Google Scholar
• Li J, Zhang Z, Bidder M, Funk M C, Nguyen L, Goodfellow P J, et al. IGSF4 promoter methylation and expression silencing in human cervical cancer. Gynecol Oncol 2005; 96: 150–158
   PubMed Web of Science ®Google Scholar
• Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh H P, et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 2001; 27: 427–430
   PubMed Web of Science ®Google Scholar
• Herman J G, Civin C I, Issa J P, Collector M I, Sharkis S J, Baylin S B. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res 1997; 57: 837–841
   PubMed Web of Science ®Google Scholar
• Matsuno N, Hoshino K, Nanri T, Kawakita T, Suzushima H, Kawano F, et al. p15 mRNA expression detected by real-time quantitative reverse transcriptase-polymerase chain reaction correlates with the methylation density of the gene in adult acute leukemia. Leuk Res 2005; 29: 557–564
   PubMed Web of Science ®Google Scholar
• Kantarjian H, Issa J P, Rosenfeld C S, Bennett J M, Albitar M, Dipersio J, et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 2006; 106: 1794–1803
   PubMed Web of Science ®Google Scholar
• Issa J P, Vertino P M, Boehm C D, Newsham I F, Baylin S B. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci USA 1996; 93: 11757–11762
   PubMed Web of Science ®Google Scholar
• Pinto A, Zagonel V. 5-Aza–2(-deoxycytidine (Decitabine) and 5-azacytidine in the treatment of acute myeloid leukemias and myelodysplastic syndromes: past, present and future trends. Leukemia 1993; 7(Suppl 1)51–60
   PubMed Web of Science ®Google Scholar
• Ross J S, Symmans W F, Pusztai L, Hortobagyi G N. Pharmacogenomics and clinical biomarkers in drug discovery and development. Am J Clin Pathol 2005; 124(Suppl)S29–S41
   PubMedGoogle Scholar
• Toyota M, Kopecky K J, Toyota M O, Jair K W, Willman C L, Issa J P. Methylation profiling in acute myeloid leukemia. Blood 2001; 97: 2823–2829
   PubMed Web of Science ®Google Scholar
• Galm O, Wilop S, Luders C, Jost E, Gehbauer G, Herman J G, et al. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia. Ann Hematol 2005; 84(Suppl 13)39–46
   PubMed Web of Science ®Google Scholar
• Nygren A O, Ameziane N, Duarte H M, Vijzelaar R N, Waisfisz Q, Hess C J, et al. Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 2005; 33: e128
   PubMed Web of Science ®Google Scholar
• Uehara E, Takeuchi S, Tasaka T, Matsuhashi Y, Yang Y, Fujita M, et al. Aberrant methylation in promoter-associated CpG islands of multiple genes in therapy-related leukemia. Int J Oncol 2003; 23: 693–696
   PubMed Web of Science ®Google Scholar
• Stiratelli R, Laird N, Ware J H. Random-effects models for serial observations with binary response. Biometrics 1984; 40: 961–971
   PubMed Web of Science ®Google Scholar
• Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333
   PubMed Web of Science ®Google Scholar
• Melki J R, Vincent P C, Clark S J. Cancer-specific region of hypermethylation identified within the HIC1 putative tumor suppressor gene in acute myeloid leukaemia. Leukemia 1999; 13: 877–883
   PubMed Web of Science ®Google Scholar
• Chen K, Sawhney R, Khan M, Benninger M S, Hou Z, Sethi S, et al. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2007; 133: 1131–1138
   PubMedGoogle Scholar
• Jeuken J W, Cornelissen S J, Vriezen M, Dekkers M M, Errami A, Sijben A, et al. MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas. Lab Invest 2007; 87: 1055–1065
   PubMed Web of Science ®Google Scholar
• Henken F E, Wilting S M, Overmeer R M, van Rietschoten J G, Nygren A O, Errami A, et al. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer 2007; 97: 1457–1464
   Google Scholar
• Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999; 59: 5438–5442
   PubMed Web of Science ®Google Scholar
• Finan K M, Hodge G, Reynolds A M, Hodge S, Holmes M D, Baker A H, et al. In vitro susceptibility to the pro-apoptotic effects of TIMP–3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs–1 or –2. Lung Cancer 2006; 53: 273–284
   PubMed Web of Science ®Google Scholar
• Feinstein E, Druck T, Kastury K, Berissi H, Goodart S A, Overhauser J, et al. Assignment of DAP1 and DAPK – genes that positively mediate programmed cell death triggered by IFN-gamma – to chromosome regions 5p12.2 and 9q34.1, respectively. Genomics 1995; 29: 305–307
   PubMed Web of Science ®Google Scholar
• Bernardini S, Bernassola F, Cortese C, Ballerini S, Melino G, Motti C, et al. Modulation of GST P1–1 activity by polymerization during apoptosis. J Cell Biochem 2000; 77: 645–653
   PubMed Web of Science ®Google Scholar
• Masuda M, Yageta M, Fukuhara H, Kuramochi M, Maruyama T, Nomoto A, et al. The tumor suppressor protein TSLC1 is involved in cell–cell adhesion. J Biol Chem 2002; 277: 31014–31019
   PubMed Web of Science ®Google Scholar
• Kremmidiotis G, Baker E, Crawford J, Eyre H J, Nahmias J, Callen D F. Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity. Genomics 1998; 49: 467–471
   PubMed Web of Science ®Google Scholar
• Kretzschmar M, Kaiser K, Lottspeich F, Meisterernst M. A novel mediator of class II gene transcription with homology to viral immediate-early transcriptional regulators. Cell 1994; 78: 525–534
   PubMedGoogle Scholar
• Scolnick D M, Halazonetis T D. Chfr defines a mitotic stress checkpoint that delays entry into metaphase. Nature 2000; 406: 430–435
   PubMed Web of Science ®Google Scholar
• Stiewe T, Putzer B M. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet 2000; 26: 464–469
   PubMed Web of Science ®Google Scholar
• Druck T, Hadaczek P, Fu T B, Ohta M, Siprashvili Z, Baffa R, et al. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res 1997; 57: 504–512
   PubMed Web of Science ®Google Scholar
• Folberg A, Nagy K E, Luo J, Giguere V, Featherstone M S. RARbeta mediates the response of Hoxd4 and Hoxb4 to exogenous retinoic acid. Dev Dyn 1999; 215: 96–107
   PubMed Web of Science ®Google Scholar
• Greene G L, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 1986; 231: 1150–1154
   PubMed Web of Science ®Google Scholar
• Scambia G, Ranelletti F O, Benedetti P P, Piantelli M, Rumi C, Battaglia F, et al. Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoids. Int J Cancer 1990; 46: 1112–1116
   PubMed Web of Science ®Google Scholar
• Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C. Estrogen receptor alpha rapidly activates the IGF–1 receptor pathway. J Biol Chem 2000; 275: 18447–18453
   PubMed Web of Science ®Google Scholar
• Issa J P, Ottaviano Y L, Celano P, Hamilton S R, Davidson N E, Baylin S B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536–540
   PubMed Web of Science ®Google Scholar
• Li L C, Shiina H, Deguchi M, Zhao H, Okino S T, Kane C J, et al. Age-dependent methylation of ESR1 gene in prostate cancer. Biochem Biophys Res Commun 2004; 321: 455–461
   PubMed Web of Science ®Google Scholar
• Christiansen D H, Andersen M K, Pedersen-Bjergaard J. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 2003; 17: 1813–1819
   PubMed Web of Science ®Google Scholar